Lincoln Pharmaceuticals Ltd Financials Statements

Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

Consolidate
Standalone
Financial Year
Sep '24
Jun '24
Mar '24
Dec '23
Sep '23
Total Qtr Revenue cr
171.19
157.69
149.51
157.47
164.68
Other Income Qtr Cr9.9810.417.0211.028.69
Operating Revenues Qtr161.21147.28142.49146.45155.99

*All values are in Cr.

Operating Expenses Qtr
132.83
124.55
124.11
116.79
124.84
Operating Profit Qtr
28.38
22.73
18.38
29.66
31.15
EBIDT Qtr Cr
38.36
33.14
25.40
40.68
39.84
Depreciation Qtr
3.22
3.22
2.69
2.81
2.58
Net Profit Qtr
26.33
23.67
18.60
28.04
27.65
Basic EPS Qtr
13.15
11.82
9.28
14.00
13.81
Open Demat Account
+91 -

personImage
Open Demat Account
+91 -